Trial intelligence / Profile preview

Sertraline for uremic pruritus in hemodialysis patients

IRCT2014080918736N1Phase 3Completed

Sponsor
Shiraz University of Medical Sciences
Start
Jun 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of sertraline in chronic kidney disease-associated pruritus (CKD-aP), sponsored by Shiraz University of Medical Sciences. Started Jun 2014; status: completed.

02

Drugs

sertraline
03

Conditions

chronic kidney disease-associated pruritus (CKD-aP)

Beyond the preview

Go deeper on IRCT2014080918736N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2014080918736N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call